Allarity Therapeutics, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

—≥ implied

Q2 FY26—▼−2.19%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.19%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

—

ALLR report session

No linked exposure.

Nov 28-KMaterial agreement: Settlement and Release Agreement with Novartis Pharma AG.Source

Oct 308-KMaterial agreement: Common Stock Purchase Agreement with Tumim Stone Capital LLC (terminated).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.